6
1
5
↑6
↓1
—5
Evidence suggests Magnesium mayincreaseMetabolism.
16 studies (12 claims)
Emerging evidence
Typical effective dose 500 (500–500) mgacross 1 dosed study
Study Claims
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| mild or moderate magnesium deficiency | Increases - contribute to | dyslipidemia and deranged lipid metabolism | Human | — | Not specified | The Role of Dietary Magnesium in Cardiovascular Disease.cited 2× |
| magnesium supplementation alone | No effect - did not show any significant improvement | markers of inflammation, OS or metabolism | Human | women with PCOS | — | The effect of magnesium alone or its combination with other supplements on the markers of inflammation, OS and metabolism in women with polycystic ovarian syndrome (PCOS): A systematic review.cited 5× |
| magnesium and melatonin supplementation | No effect - effect on the markers of metabolism needs to be further verified | markers of metabolism | Human | — | — | The effect of magnesium alone or its combination with other supplements on the markers of inflammation, OS and metabolism in women with polycystic ovarian syndrome (PCOS): A systematic review.cited 5× |
| Magnesium combined with vitamin E or zinc-calcium-vitamin D | Increases - significantly improved | glucose and lipid metabolism | Human | PCOS patients | — | The effect of magnesium alone or its combination with other supplements on the markers of inflammation, OS and metabolism in women with polycystic ovarian syndrome (PCOS): A systematic review.cited 5× |
| magnesium supplementation | Increases - improved | alactic anaerobic metabolism | Human | professional male volleyball players | 350 mg Mg per day for the experimental group, 500 mg maltodextrin per day for the control group. | Magnesium status and the physical performance of volleyball players: effects of magnesium supplementation.cited 18× |
| magnesium supplementation | No effect - beneficial effects | glucose metabolism and insulin sensitivity | Human | — | Not specified | The role of magnesium in type 2 diabetes: a brief based-clinical review.cited 40× |
| magnesium supplementation | No effect - results are controversial | glucose metabolism and insulin sensitivity | Human | — | Not specified | The role of magnesium in type 2 diabetes: a brief based-clinical review.cited 40× |
| magnesium | No effect - exerts an essential role | glucose metabolism | Human | — | Not specified | The role of magnesium in type 2 diabetes: a brief based-clinical review.cited 40× |
| Magnesium supplementation | Increases - improves | lipid metabolism | Human | — | Not specified | Magnesium and cardiovascular system.cited 86× |
| Magnesium supplementation | Increases - improves | myocardial metabolism | Human | — | Not specified | Magnesium and cardiovascular system.cited 86× |
| magnesium supplementation | No effect - differentially affects | vitamin D metabolism | Human | participants aged 40-85 y | — | Magnesium status and supplementation influence vitamin D status and metabolism: results from a randomized trial.cited 110× |
| Magnesium | No effect - intervenes in | enzymatic reactions of the energetic metabolism | Human | — | 60 mg Magnolia bark extract (once daily, as part of ES formulation). | Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium. Controlled clinical study in menopause.cited 32× |
| magnesium | No effect - can interact with | vitamin D metabolism and activity | Human | — | Not provided | Zinc, Magnesium and Vitamin K Supplementation in Vitamin D Deficiency: Pathophysiological Background and Implications for Clinical Practice.cited 5× |
| Selenium and magnesium co-supplementation | No effect - regulated | mRNA expression levels of liver enzymes related to cholesterol metabolism | Animal | hyperlipidemia rats | — | Effects of oral selenium and magnesium co-supplementation on lipid metabolism, antioxidative status, histopathological lesions, and related gene expression in rats fed a high-fat diet. |
| magnesium administration | No effect - without concerns for negative interference | bone metabolism | Human | people with CKD | Daily dosage of elemental magnesium varied highly between studies (not specified). | Magnesium Administration in Chronic Kidney Disease.cited 18× |
| magnesium administration | Increases - could improve | parameters of vascular function and calcification and mineral metabolism | Human | people with CKD | Daily dosage of elemental magnesium varied highly between studies (not specified). | Magnesium Administration in Chronic Kidney Disease.cited 18× |
| magnesium-zinc-calcium-vitamin D co-supplementation | No effect - had beneficial effects | insulin metabolism | Human | patients with PCOS | 100 mg magnesium, 4 mg zinc, 400 mg calcium, and 200 IU vitamin D twice daily | A Trial on The Effects of Magnesium-Zinc-Calcium-Vitamin D Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome.cited 15× |
| magnesium citrate supplementation | Decreases - aims to modulate | the complex and deregulated mineral metabolism leading to vascular calcification and arterial stiffness | Human | stage 3-4 CKD patients without overt hyperphosphatemia | Not specified in the abstract. | Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease.cited 6× |
| magnesium deficiency | No effect - suggest a possible role in | bone metabolism | Human | alternate study populations, animal experiments or in vitro studies | Not specified | Hypomagnesaemia in kidney transplantation.cited 31× |